Skip to main navigation Skip to search Skip to main content

Streptozotocin-induced diabetic ketoacidosis in a patient with metastatic islet-cell carcinoma

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

Here we report a severe life-threatening complication of treatment with streptozotocin in a patient with pancreatic island-cell carcinoma. The patient was admitted to the intensive care unit with severe diabetic ketoacidosis which needed aggressive fluid resuscitation and insulin therapy. We believe it is critical to be aware of the symptoms of diabetic ketoacidosis and monitor glucose levels during streptozotocin treatment
Original languageEnglish
Pages (from-to)541-542
JournalNetherlands journal of medicine
Volume71
Issue number10
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Streptozotocin-induced diabetic ketoacidosis in a patient with metastatic islet-cell carcinoma'. Together they form a unique fingerprint.

Cite this